Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
The Journal of Infectious Diseases
|
November 19, 2003
Oral administration of beta-lactamase preserves colonization resistance of piperacillin-treated mice
Usha Stiefel, Nicole J Pultz, Jaana Harmoinen, et al.
American Journal of Infection Control
|
June 14, 2003
Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococci
Richard A Mayer, Rula C Geha, Marion S Helfand, et al.
Biochemistry
|
November 19, 2003
Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography
Marion S Helfand, Monica A Totir, Marianne P Carey, et al.
The Journal of Biological Chemistry
|
October 10, 2003
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130
Marion S Helfand, Christopher R Bethel, Andrea M Hujer, et al.
Biochemistry
|
July 17, 2007
Sulbactam forms only minimal amounts of irreversible acrylate-enzyme with SHV-1 beta-lactamase
Monica A Totir, Marion S Helfand, Marianne P Carey, et al.
Psychopharmacology
|
May 21, 2009
The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress
Sandeep Kumar, Patrizia Porcu, David F Werner, et al.
Biochemistry
|
September 28, 2006
Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates
Monica A Totir, Pius S Padayatti, Marion S Helfand, et al.
Biochemistry
|
June 28, 2007
Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors
Marion S Helfand, Magdalena A Taracila, Monica A Totir, et al.
The Journal of Biological Chemistry
|
August 2, 2005
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase
Pius S Padayatti, Marion S Helfand, Monica A Totir, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|
December 1, 1996
Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis
R S Wallis, M S Helfand, C C Whalen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
The Journal of Infectious Diseases
|
November 19, 2003
Oral administration of beta-lactamase preserves colonization resistance of piperacillin-treated mice
Usha Stiefel, Nicole J Pultz, Jaana Harmoinen, et al.
American Journal of Infection Control
|
June 14, 2003
Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococci
Richard A Mayer, Rula C Geha, Marion S Helfand, et al.
Biochemistry
|
November 19, 2003
Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography
Marion S Helfand, Monica A Totir, Marianne P Carey, et al.
The Journal of Biological Chemistry
|
October 10, 2003
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130
Marion S Helfand, Christopher R Bethel, Andrea M Hujer, et al.
Biochemistry
|
July 17, 2007
Sulbactam forms only minimal amounts of irreversible acrylate-enzyme with SHV-1 beta-lactamase
Monica A Totir, Marion S Helfand, Marianne P Carey, et al.
Psychopharmacology
|
May 21, 2009
The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress
Sandeep Kumar, Patrizia Porcu, David F Werner, et al.
Biochemistry
|
September 28, 2006
Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates
Monica A Totir, Pius S Padayatti, Marion S Helfand, et al.
Biochemistry
|
June 28, 2007
Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors
Marion S Helfand, Magdalena A Taracila, Monica A Totir, et al.
The Journal of Biological Chemistry
|
August 2, 2005
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase
Pius S Padayatti, Marion S Helfand, Monica A Totir, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|
December 1, 1996
Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis
R S Wallis, M S Helfand, C C Whalen, et al.
Page
of 4